MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 413.607
NA - Nord America 19.118
AS - Asia 2.655
SA - Sud America 75
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 20
OC - Oceania 17
Totale 435.513
Nazione #
IT - Italia 408.716
US - Stati Uniti d'America 18.987
CN - Cina 1.905
UA - Ucraina 1.820
SE - Svezia 1.035
GB - Regno Unito 552
DE - Germania 540
SG - Singapore 524
FI - Finlandia 506
FR - Francia 177
CA - Canada 119
BR - Brasile 71
NL - Olanda 54
IN - India 53
RU - Federazione Russa 43
BE - Belgio 42
VN - Vietnam 41
KR - Corea 33
EU - Europa 21
CZ - Repubblica Ceca 18
ES - Italia 18
IR - Iran 17
AT - Austria 15
AU - Australia 15
IL - Israele 15
HK - Hong Kong 12
RO - Romania 10
TR - Turchia 9
IE - Irlanda 8
JP - Giappone 8
MU - Mauritius 8
CH - Svizzera 7
MX - Messico 6
PL - Polonia 6
ZA - Sudafrica 6
AL - Albania 5
AZ - Azerbaigian 5
LT - Lituania 4
NO - Norvegia 4
PT - Portogallo 4
UZ - Uzbekistan 4
CU - Cuba 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
TH - Thailandia 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EC - Ecuador 2
KH - Cambogia 2
MA - Marocco 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
AF - Afghanistan, Repubblica islamica di 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MC - Monaco 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
TW - Taiwan 1
Totale 435.513
Città #
Cagliari 401.621
Uta 5.956
Fairfield 2.579
Woodbridge 2.181
Chandler 1.570
Houston 1.433
Ashburn 1.403
Wilmington 1.146
Ann Arbor 1.055
Seattle 1.007
Boardman 932
Jacksonville 900
Cambridge 861
Nyköping 722
Dearborn 400
Nanjing 352
Beijing 256
Singapore 249
Boston 233
Helsinki 218
Santa Clara 211
Shanghai 204
New York 191
Milan 153
San Diego 133
Shenyang 126
Nanchang 105
Toronto 96
Hebei 91
Redwood City 90
Guangzhou 89
Jiaxing 86
Norwalk 83
Verona 82
Changsha 75
Munich 66
London 62
Los Angeles 62
Washington 60
Sassari 56
Tianjin 48
Mountain View 46
Jinan 43
Dong Ket 40
Zhengzhou 40
Ningbo 37
Hangzhou 36
Atlanta 34
Auburn Hills 32
Brussels 32
Orange 30
Hefei 27
Kunming 27
Pune 26
Taizhou 26
Seoul 25
Rome 24
Council Bluffs 19
Falls Church 18
Millbury 16
Phoenix 15
Wuhan 14
Chicago 13
Edinburgh 13
Amsterdam 12
Borås 12
Saint Petersburg 12
Brno 11
Indiana 11
Augusta 10
Domusnovas 10
Kilburn 10
Redmond 10
Fuzhou 9
Hong Kong 9
Nuremberg 9
Detroit 8
Leawood 8
Madrid 8
Dublin 7
Palermo 7
San Mateo 7
Shenzhen 7
Stockholm 7
São Paulo 7
Vienna 7
Ardabil 6
Chengdu 6
Chiswick 6
Haikou 6
Meana Sardo 6
Newark 6
Nürnberg 6
Perth 6
San Francisco 6
Simi Valley 6
Tel Aviv 6
Turin 6
Wuxi 6
Baku 5
Totale 428.157
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.094
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.842
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.127
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.853
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.484
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.411
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.391
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.323
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.237
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.201
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.129
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.128
Overexpression of the cytokine BAFF and autoimmunity risk 3.973
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.937
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.934
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.840
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.818
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.778
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.768
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.740
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.739
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.724
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.634
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.610
Walking improvements with nabiximols in patients with multiple sclerosis 3.601
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.587
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.535
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.508
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.504
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.473
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.356
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.335
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.325
Impact of the media on future hope in multiple sclerosis 3.323
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.224
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.220
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.215
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.165
Oral agents in multiple sclerosis 3.154
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.146
Influence of treatments in multiple sclerosis disability: a cohort study 3.106
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.017
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 2.995
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. 2.985
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 2.980
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 2.946
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.916
Refining the connection between gait and cognition: training the body to improve the brain 2.905
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.897
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.891
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.856
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.804
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.774
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.755
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.659
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.596
Postural adaptation during a Nintendo Wii balance training 2.587
Perception of risk and shared decision making process in multiple sclerosis 2.585
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.577
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.540
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.494
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.492
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.482
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.447
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.441
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.377
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.356
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.351
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.276
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.263
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.257
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.250
The cohort of the multiple sclerosis center of Cagliari 2.249
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.224
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.223
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.211
Induction and escalation therapies in multiple sclerosis 2.208
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.196
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.196
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.184
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.153
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.126
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.043
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.026
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 1.994
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 1.991
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 1.989
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 1.983
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 1.973
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 1.966
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 1.941
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.921
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.874
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.862
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.850
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.845
The Italian multiple sclerosis register 1.839
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.825
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.823
The risk of bipolar disorders in multiple sclerosis 1.823
Totale 296.781
Categoria #
all - tutte 529.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 529.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.185 0 0 0 0 0 0 0 2.521 1.587 1.753 1.716 4.608
2020/2021105.907 3.083 4.062 4.857 24.794 19.140 13.273 9.905 7.691 3.352 6.296 5.866 3.588
2021/202219.556 2.607 1.488 880 1.633 1.641 1.192 889 965 1.828 1.971 2.385 2.077
2022/202325.350 2.402 3.590 3.378 2.013 1.979 2.639 1.023 2.262 1.502 1.567 1.827 1.168
2023/202425.660 1.721 1.382 921 1.912 2.647 4.002 2.760 2.239 1.272 2.171 2.484 2.149
2024/202564.581 22.227 21.162 7.722 4.139 2.672 2.760 3.738 161 0 0 0 0
Totale 436.251